Oligofructose clinical trials
How each study uses oligofructose is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the oligofructose studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Oligofructose
- 5
Studies by the year they started
7 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- No phase
- 7
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 7
Imperial College London (1) · Oslo University Hospital (1) · University of Nottingham (1) · Medical University of Warsaw (1) · University of Calgary (1) · Princess Nourah Bint Abdulrahman University (1) · Children's Hospital of Fudan University (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test oligofructose.
- Sep 2027Effect of Prebiotics in Saudi Adults With Type 2 DiabetesNot applicable · Princess Nourah Bint Abdulrahman University
Studies
Open first, then newest update. How each study uses oligofructose is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and ProbioticsRecruitingNot applicableChildren's Hospital of Fudan UniversityNCT05791604Written as Prebiotics with galactomannan and oligofructose
- Effect of Prebiotics in Saudi Adults With Type 2 DiabetesNot yet recruitingNot applicablePrincess Nourah Bint Abdulrahman UniversityNCT07464691Written as oligofructose
- Effect of Oligofructose on Appetite in Overweight SubjectsCompletedNot applicableImperial College LondonNCT00912197Written as Oligofructose
- Effects of Prebiotics on GLP-1 in Type 2 DiabetesCompletedNot applicableOslo University HospitalNCT02569684Written as Prebiotic fibers: oligofructose and inulin
- The Effect of the Low FODMAP Diet and Dietary Oligofructose on Gastrointestinal Form, Function and MicrobiotaCompletedNot applicableUniversity of NottinghamNCT02259465Written as Oligofructose
- The Effect of the Oligofructose Supplementation on Body Weight in Overweight and Obese ChildrenCompletedNot applicableMedical University of WarsawNCT01673152Written as Oligofructose
- Prebiotic Fiber as a Modifier of Satiety Hormones and Body Weight in Overweight and Obese AdultsCompletedNot applicableUniversity of CalgaryNCT00522353Written as Oligofructose
Codes
What other systems call oligofructose · ClinicalTrials.gg INT004171
- MeSH (NLM) C120489oligofructoseOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C120489 | oligofructose | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.